These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 30299265)

  • 61. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls.
    Lanzo E; Monge M; Trent M
    Pediatr Ann; 2015 Sep; 44(9):e223-30. PubMed ID: 26431241
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy.
    Patel S
    J Steroid Biochem Mol Biol; 2018 Sep; 182():27-36. PubMed ID: 29678491
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pregnancy complications in women with polycystic ovary syndrome.
    Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
    Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
    Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
    Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.
    Ganie MA; Vasudevan V; Wani IA; Baba MS; Arif T; Rashid A
    Indian J Med Res; 2019 Oct; 150(4):333-344. PubMed ID: 31823915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.
    Paixão L; Ramos RB; Lavarda A; Morsh DM; Spritzer PM
    Reprod Biol Endocrinol; 2017 Feb; 15(1):12. PubMed ID: 28183310
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity.
    Chiu WL; Boyle J; Vincent A; Teede H; Moran LJ
    Neuroendocrinology; 2017; 104(4):412-424. PubMed ID: 28006770
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
    Diamanti-Kandarakis E
    Expert Rev Mol Med; 2008 Jan; 10():e3. PubMed ID: 18230193
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review.
    Maleki V; Izadi A; Farsad-Naeimi A; Alizadeh M
    Nutr Res; 2018 Aug; 56():1-10. PubMed ID: 30055769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypothalamic DNA methylation in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture.
    Cui P; Ma T; Tamadon A; Han S; Li B; Chen Z; An X; Shao LR; Wang Y; Feng Y
    Exp Physiol; 2018 Dec; 103(12):1618-1632. PubMed ID: 30204276
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dietary therapy in polycystic ovary syndrome.
    Moran LJ; Brinkworth GD; Norman RJ
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Insulin-lowering agents in the management of polycystic ovary syndrome.
    De Leo V; la Marca A; Petraglia F
    Endocr Rev; 2003 Oct; 24(5):633-67. PubMed ID: 14570747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome.
    Di Bari F; Catalano A; Bellone F; Martino G; Benvenga S
    Metabolites; 2021 Feb; 11(2):. PubMed ID: 33670644
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of maternal PCOS and PCOS-like phenotype on the offspring's health.
    Puttabyatappa M; Cardoso RC; Padmanabhan V
    Mol Cell Endocrinol; 2016 Nov; 435():29-39. PubMed ID: 26639019
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lifestyle changes in women with polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Norman RJ; Teede HJ
    Cochrane Database Syst Rev; 2011 Feb; (2):CD007506. PubMed ID: 21328294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.